Singulair 4 mg 14 chewable tablets

Tradename

Singulair

Composition

Each chewable tablet contains:

Montelukast Sodium — 4mg.

Auxiliary components: mannitol, microcrystalline cellulose, hydroxypropyl cellulose, red iron oxide, croscarmellose sodium, cherry flavor, aspartame, magnesium stearate.

Properties

Montelukast is a highly active drug that significantly improves inflammation in bronchial asthma. Blocks the development of bronchospasm, reduces the number of eosinophils in the respiratory tract and in the peripheral blood. Steroid free.

Indications

Prevention and long-term treatment of bronchial asthma in children from 2 to 5 ye in order to control the day and night symptoms of the disease; relief of symptoms of allergic rhinitis in children 2 to 5 years of age.

Treatment of allergic rhinitis in patients with bronchial asthma.

Mode of application:

Contraindications

Children under 2 years old; hypersensitivity drug components; phenylketonuria; pregna and lactation.

Precautions:

It is not recommended to prescribe for the treatment of acute attacks of bronchial asthma. Patients should be instructed to always carry emergency medications for asthma attacks (short-acting inhaled beta2-agonists). For elderly patients, patients with renal insufficiency, as well as patients with mild or moderate hepatic dysfunction, and also depending on gender, special dose selection is not required.

Side effects

The drug is well tolerated. You may experience: dizziness, drowsiness, tiredness; increased tendency to bleeding; diarrhea, nausea, vomiting, pancreatitis; hepatitis; hypersensitivity reaction, itching, rash, urticaria; anxiety, depression, impaired attention, memory impairment, insomnia; heart palpitations; nosebleeds; arthralgia, myalgia, muscle cramps; swelling.

Storage

Keep out of the reach of children.

Packaging:

The package contains 14 tablets, paper